United States · 
Who invested in Optate?
Optate's investors include Ascend Venture Group, Opportunity Capital Partners and Internet Healthcare Group.
2002
$6.5MSeries B$1.8MVentureUnited States · Venture startup
Who invested in Optate
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$8.3Mraised across 2 rounds since 2001, from 2 sources
$6.5MSeries B$1.8MVenture
- Latest round
- Venture, $1.8MNov 2002
- Biggest round
- $6.5MSeries B · Sept 2001
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $6.5M Sept 2001
- Biggest round
- $6.5M Series B · Sept 2001
- Between rounds
- 14 months from the last two
The rounds
- Nov 2002Venture$1.8M1 new2 returning
From a historical funding record
- Sept 2001
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
The exit
ExitBuyerPriceWhen
AcquiredWebMDundisclosedApr 2003
From historical deal records. Wrong? Tell us.
Everyone who backed them
Ascend Venture GroupGrowth equity2rounds
Internet Healthcare GroupVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Optate
How much has Optate raised?
Optate has raised $8.3M across 2 rounds since 2001.
When did Optate last raise?
Optate's most recent round was a Venture of $1.8M in Nov 2002.
What was Optate's biggest round?
Optate's largest round on record is $6.5M (Series B), in Sept 2001.
Who backed Optate first?
Optate's first round on record, in Sept 2001, was backed by Ascend Venture Group and Opportunity Capital Partners.
What stage is Optate at?
Optate's latest named round is a Venture, in Nov 2002.
Where is Optate based?
Optate is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.